EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nuclear cGAS governs transcription to control lipid metabolism, tumor growth, and therapy response

Yu Deng, Matthew J Niederhuber, Zhichuan Zhu, Austin J Hepperla, Le Yu, Quentin Hahn, Joshua Hartsell, Tooba Rashid, Piotr A Mieczkowski, Hemant Kelkar, Jeremy M Simon, Yanqiong Zhang und 16 weitere

Journal of Clinical Investigation · 02.11.2026 · 136 (21)

DOI: 10.1172/jci205579 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 02.11.2026. Verfasst von Yu Deng und 27 weiteren Autor:innen. Beteiligte Einrichtung: Lineberger Comprehensive Cancer Center. Hauptthemen laut MEDLINE: Nucleotidyltransferases, Lipid Metabolism, Transcription, Genetic, Cell Nucleus. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclic GMP-AMP synthase (cGAS) is a cytosolic DNA sensor critical for host defense against microbial infections. To prevent aberrant activation, nuclear cGAS is restrained by nucleosome tethering or by barrier-to-autointegration factor–mediated restriction of its access to DNA. However, its physiological roles beyond enzymatic suppression in the nucleus remain poorly understood. Here, we present a genome-wide map of cGAS chromatin localization in human cells and unexpectedly find its binding beyond nucleosome tethering, where cGAS is recruited to chromatin by AP-1 transcription factors via a potentially previously uncharacterized transactivation domain. Integrated CUT & RUN , RNA-seq, and metabolomics analyses reveal that cGAS transcriptionally regulates cholesterol homeostasis. Mechanistically, cGAS promotes LGALS3 transcription, which inhibits ACAA2 activity to suppress fatty acid oxidation and acetyl-CoA production, thereby lowering intracellular cholesterol levels. Reduced cholesterol lowers plasma membrane phosphatidylinositol [3,4,5] triphosphate [PI(3,4,5)P 3 ] levels and decreases mTOR complex 2 (mTORC2) activation. In contrast, cGAS depletion results in cholesterol accumulation and elevated PI(3,4,5)P 3 , driving mTORC2/Akt signaling, promoting xenografted tumor growth, and conferring resistance to DNA-damaging agents. In vivo, the elevated hepatic cholesterol levels observed in cGas –/– mice were largely reversed by inhibition of Akt but not STING, whereas cGAS deficiency had minimal effects on lung physiology. Collectively, our findings uncover an unexpected role for nuclear cGAS in orchestrating a transcriptional program that links lipid metabolism to cell proliferation, stress response, and cholesterol homeostasis in liver.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NucleotidyltransferasesLipid MetabolismTranscription, GeneticCell NucleusNeoplasm ProteinsNeoplasms, ExperimentalHumansCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseAnimalsMiceFemaleCholesterol

Stichwörter der Autor:innen

Cell biologyEpigeneticsMetabolismOncology

Substanzen

Cyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseNucleotidyltransferasescGAS protein, humancGAS protein, mouseNeoplasm ProteinsCholesterol

Autor:innen und Institutionen

  • Lineberger Comprehensive Cancer Center.
  • Department of Biochemistry and Biophysics.
  • Bioinformatics and Analytics Research Collaborative (BARC).
  • Carolina Institute for Developmental Disabilities.
  • University of North Carolina (UNC) Neuroscience Center, and.
  • Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Förderung

  • NIGMS NIH HHS
  • NCI NIH HHS
  • NIA NIH HHS
  • NIDDK NIH HHS
  • National Institute of Health
  • U.S. Department of Defense

Zitieren

APA

Deng, Y., Niederhuber, M. J., Zhu, Z., Hepperla, A. J., Yu, L., Hahn, Q., Hartsell, J., Rashid, T., Mieczkowski, P. A., Kelkar, H., Simon, J. M., Zhang, Y., Livraghi-Butrico, A., Zeller, M. J., Kennedy, J. G., DePriest, J. F., Li, J., Zhang, Y., Qiu, X., …, & Liu, P. (2026). Nuclear cGAS governs transcription to control lipid metabolism, tumor growth, and therapy response. Journal of Clinical Investigation, 136(21). https://doi.org/10.1172/jci205579

Vancouver

Deng Y, Niederhuber MJ, Zhu Z, Hepperla AJ, Yu L, Hahn Q, et al. Nuclear cGAS governs transcription to control lipid metabolism, tumor growth, and therapy response. Journal of Clinical Investigation. 2026;136(21). doi:10.1172/jci205579

BibTeX
@article{Deng2026,
  author = {Deng, Yu and Niederhuber, Matthew J and Zhu, Zhichuan and Hepperla, Austin J and Yu, Le and Hahn, Quentin and Hartsell, Joshua and Rashid, Tooba and Mieczkowski, Piotr A and Kelkar, Hemant and Simon, Jeremy M and Zhang, Yanqiong and Livraghi-Butrico, Alessandra and Zeller, Meredith J and Kennedy, Joseph Gc and DePriest, Jazmin F and Li, Jiong and Zhang, Yan and Qiu, Xing and Kaniskan, H Ümit and Jin, Jian and Jones, Corbin D and Herring, Laura E and Phanstiel, Douglas H and Liu, Xiaojing and Raab, Jesse R and Strahl, Brian D and Liu, Pengda},
  title = {Nuclear cGAS governs transcription to control lipid metabolism, tumor growth, and therapy response},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {21},
  doi = {10.1172/jci205579}
}
Kostenlos starten →